mdlinx mdlinx

Urology - Oncology News & Articles

Now available on MDLinx Urology, find daily updates summarizing the top literature from over 2,000 peer-reviewed journals, including Journal of Urology, European Urology, The Prostate, and more. Find coverage of the kidney, bladder, penis/urethra and prostate. View article summaries by subspecialty and disease state, including peds urology, urologic oncology, stone disease, infections and STDs, urologic imaging, ureteral disease, voiding and incontinence, infertility, laparoscopy and other surgical techniques, and additional hot topics in your field. Find exclusive content only available on MDLinx Urology like articles highlighted by physician editor D. Scott Cunningham, MD, PhD, and clinical pearls gleaned from The Smartest Doc quiz competitions and Physician Reviews.

Your Unread Messages in Urology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Articles

Latest (14) Full Text Articles (345)
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

181 Prostate volume as an independent predictor of prostate cancer in men with PSA of 10-50 ng ml-1 Asian Journal of Andrology, April 24, 2013    Clinical Article

182 Daily life and life quality 3 years following prostate cancer treatment Full Text BMC Nursing, April 24, 2013    Clinical Article

183 Relationship between predictors of the risk of clinical progression of benign prostatic hyperplasia and metabolic syndrome in men with moderate to severe lower urinary tract symptoms Urology, April 24, 2013    Clinical Article

184 Differential diagnosis between bacterial infection and neoplastic fever in patients with advanced urological cancer: The role of procalcitonin International Journal of Urology, April 24, 2013    Clinical Article

185 The prostate cancer-up-regulated myc-associated zinc-finger protein (MAZ) modulates proliferation and metastasis through reciprocal regulation of androgen receptor Medical Oncology, April 24, 2013    Clinical Article

186 CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer Cancer Research, April 24, 2013    Clinical Article

187 Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis The Journal of Urology, April 24, 2013    Clinical Article

188 Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis The Journal of Urology, April 24, 2013    Clinical Article

189 Arylamine Adducts and Bladder Cancer in Lifelong Nonsmokers Cancer Epidemiology, Biomarkers & Prevention, April 24, 2013    Clinical Article

190 Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone Cancer Treatment Reviews, April 24, 2013    Clinical Article

191 Overexpression of RING box protein-1 (RBX1) associated with poor prognosis of non-Muscle-Invasive bladder transitional cell carcinoma Journal of Surgical Oncology, April 24, 2013    Clinical Article

192 Do patients with metastatic urothelial carcinoma benefit from docetaxel as second-line chemotherapy Clinical and Translational Oncology, April 24, 2013    Clinical Article

193 Novel chemotherapies in development for management of castration-resistant prostate cancer Current Opinion in Urology, April 23, 2013    Review Article    Clinical Article

194 Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study British Medical Journal, April 23, 2013    Clinical Article

195 Castrate-resistant prostate cancer: postdocetaxel management Current Opinion in Urology, April 23, 2013    Review Article    Clinical Article

196 Diagnosis of relevant prostate cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsies Magnetic Resonance Imaging, April 23, 2013    Clinical Article

197 Management of castrate resistant prostate cancer--recent advances and optimal sequence of treatments Current Urology Reports, April 23, 2013    Clinical Article

198 Imaging of castration-resistant prostrate cancer: development of imaging response biomarkers Current Opinion in Urology, April 23, 2013    Clinical Article

199 Molecular pathology of prostate cancer revealed by next-generation sequencing: opportunities for genome-based personalized therapy Current Opinion in Urology, April 23, 2013    Review Article

200 Prostate cancer risk-associated genetic markers and their potential clinical utility Asian Journal of Andrology, April 23, 2013    Clinical Article

50 available pages First Previous 10 11 12 13 14 15 16 17 18 19 Next Last

Clinical Pearls in Urology

Highlights in Urology

Red meat cooked at high temperatures increases risk of advanced cancer of the prostate

Researchers at the University of Southern California have reported a risk between advanced cancer of the prostate and red meats cooked at high temperature, pan-frying, and prepared "well done." The study involved 1140 men with advanced cancer of the prostate, 717 men with localized cancer of the prostate, and 1096 healthy controls from the California Collaborative Prostate Cancer Study. There was an inverse association between baked poultry and advanced prostate cancer.

Read the article summary

Risk factors for delirium post-radical cystectomy

Researchers at the University of Chicago Pritzker School of Medicine have reported that older age and the pre-operative MMSE results are associated with post-radical cystectomy (OR = 1.52) in patients > 65 years of age (n=49). The incidence of post-operative delirium was 29%. Further, patients with post-operative delirium were at increased risk for readmission (OR = 10.7) and re-operation (OR = 9.2).

Read the article summary

PSA screening reduces risk of metastatic cancer of the prostate

As published in European Neurology, men (age range, 55-69 years) who undergo PSA screening are at decreased risk for metastatic cancer of the prostate. The study involved 76,813 men with a median follow-up of 12 y. There were 666 cases with metastatic cancer of the prostate(256 screened [.67%/1000] and 410 non-screened [.86%/1000]). The HR for men who were screened was 0.58.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Urology Articles

Last month's top read Top Articles of 2012

1 Androgen annihilation as a new therapeutic paradigm in advanced prostate cancer Current Opinion in Urology, April 8, 2013    Review Article

2 Low serum testosterone levels are predictive of prostate cancer World Journal of Urology, April 9, 2013

3 Early versus deferred androgen suppression therapy for patients with lymph node-positive prostate cancer after local therapy with curative intent: a systematic review BMC Cancer, March 21, 2013    Free full text    Evidence Based Medicine    Review Article

4 Morbidity of focal therapy in the treatment of localized prostate cancer European Urology, April 1, 2013    Free full text

5 Six-month leuprorelin acetate depot formulations in advanced prostate cancer: a clinical evaluation Clinical Interventions in Aging, April 29, 2013    Free full text

6 Minireview: Androgen Metabolism in Castration-Resistant Prostate Cancer Molecular Endocrinology, April 17, 2013    Review Article

7 Associations of tea and coffee consumption with prostate cancer risk Cancer Causes and Control, April 22, 2013

8 A randomized clinical study to compare the efficacy and safety of naftopidil versus tamsulosin in symptomatic benign prostatic hyperplasia UroToday International Journal, April 3, 2013
Exclusive Author Commentary

9 Consideration of comorbidity in risk stratification prior to prostate biopsy Cancer, April 26, 2013

10 Surgical castration for androgen-deprivation therapy of prostate cancer – relevance in current practice Journal of Clinical Urology, April 2, 2013

11 Do patients with metastatic urothelial carcinoma benefit from docetaxel as second-line chemotherapy Clinical and Translational Oncology, April 24, 2013

12 Impact of smoking and smoking cessation on oncologic outcomes in primary non–muscle-invasive bladder cancer European Urology, March 27, 2013    Free full text

13 Prostate volume as an independent predictor of prostate cancer in men with PSA of 10-50 ng ml-1 Asian Journal of Andrology, April 24, 2013

14 Hypofractionated external-beam radiation therapy (HEBRT) versus conventional external-beam radiation (CEBRT) in patients with localized prostate cancer: a systematic review and meta-analysis Core Evidence, March 18, 2013

15 Prostate cancer prevention: strategies for agent development Current Opinion in Oncology, April 16, 2013    Review Article

16 Phase III, randomized, placebo-controlled study of docetaxel in combination with zibotentan in patients with metastatic castration-resistant prostate cancer Journal of Clinical Oncology, April 10, 2013

17 Prevalence of patients with nonmetastatic prostate cancer on androgen deprivation therapy in the United States Urology, April 19, 2013

18 Zinc and zinc transporters in prostate carcinogenesis Nature Reviews Urology, March 13, 2013

19 Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study Prostate Cancer & Prostatic Diseases, April 11, 2013

20 Is lycopene an effective agent for preventing prostate cancer? Cancer Prevention Research, March 14, 2013    Review Article

Indexed Journals in Urology: Urology, Journal of Urology, European Urology, The Prostatemore

Other Topics in Urology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close